| Author/Editor | Tešić, Nataša; Pekle Simonič, Iza; Roškar, Katja; Rožman, Primož; Švajger, Urban | |
| Title | Dendritic cells generated in the presence of platelet lysate have a reduced type 1 polarization capacity | |
| Type | članek | |
| Publication year | 2019 | |
| Volume | str. str. | |
| ISSN | 0882-0139 - Immunological investigations | |
| Language | eng | |
| Abstract | Previously, we have shown platelet lysate (PL) can be used as a nonxenogeneic serum supplement for generation of monocyte-derived dendritic cells (DCs). Since DC-based activation protocols are extremely sensitive to microenvironmental changes such as replacement of culture medium, we wanted to examine the behavior of DCs cultured in the presence of PL under various type-1 activation conditions and assess their type 1 polarization capacity. We compared the quality of DCs cultured in 10% PL-supplemented RPMI medium (plDCs) with clinical-grade DCs obtained using commercially available serum-free medium (sfDCs), frequently used in established DC vaccine protocols. The DC maturation protocols consisted of either monophosphoryl lipid A/IFN-[gamma], poly I:C/TNF-[alpha]/IFN-[alpha] or poly I:C/R848. In general, plDCs were inferior to sfDCs in most aspects of their functional type 1 polarization characteristics. After maturation, the expression of co-stimulatory, HLA class II and lymph node-homing molecules was strongly up-regulated, with some noticeable differences. The expression of CD80 and CD86 was more extensive on plDCs, which was particularly evident in case of CCR7. However, after observing their functional capacity, plDCs had significantly lower allo-stimulatory capacity both in terms of CD4+ and CD8+ T cell stimulation. The high expression of CCR7 corresponded to higher CCL-19 directed DC migration of plDCs compared to sfDCs. Finally, their capacity to induce granzyme B and IFN-[gamma] production in CD8+ T cells was significantly reduced in comparison to sfDCs. Based on these findings, the use of PL as an alternative serum supplement for generation of monocyte-derived DC anti-tumor vaccines is questionable. | |
| Keywords | dendritic cells platelet lysate cancer vaccines dendritične celice trombocitov lizat cepiva proti raku |